A Study to Evaluate the Effect of Rifampin on the Single-dose Pharmacokinetics of BMS-986177 in Healthy Subjects
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Bristol-Myers Squibb
Related studies linked through entity extraction aliases.
Apixaban for Primary Prevention of Venous Thromboembolism in Patients With Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE4
A Study to Evaluate the Effect of Rifampin on the Single-dose Pharmacokinetics (PK) of BMS-986141 in Healthy Subjects
- Status
- COMPLETED
- Phase
- PHASE1
Dasatinib and Osimertinib (AZD9291) in Advanced Non-Small Cell Lung Cancer With EGFR Mutations
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
NeoVax Plus Ipilimumab in Renal Cell Carcinoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Study of BMS-986012 in Subjects With Small Cell Lung Caner
- Status
- COMPLETED
- Phase
- PHASE1
Trial to Evaluate Anticoagulation Therapy in Hemodialysis Patients With Atrial Fibrillation
- Status
- COMPLETED
- Phase
- PHASE4
Real-Life Effectiveness and Safety in Participants With Advanced/Metastatic Renal Cell Carcinoma Starting 1st Line Nivolumab and Ipilimumab Combination Therapy or Nivolumab Monotherapy After Prior Therapy
- Status
- COMPLETED
- Phase
- N/A
Precision Medicine Offers Belatacept Monotherapy
- Status
- WITHDRAWN
- Phase
- PHASE4
Ipilimumab and Nivolumab in Leptomeningeal Metastases
- Status
- COMPLETED
- Phase
- PHASE2
Apixaban Discontinuation Prior to Major Surgery
- Status
- COMPLETED
- Phase
- N/A
A Study to Test Combination Treatments in Participants With Advanced Gastric Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Compare Apixaban and Vitamin-K Antagonists in Patients With Atrial Fibrillation (AF) and End-Stage Kidney Disease (ESKD)
- Status
- COMPLETED
- Phase
- PHASE3
Cohort of Patients With NSCLC Treated With Nivolumab Under the ATU Program
- Status
- COMPLETED
- Phase
- N/A
Study With Healthy Japanese and Non-Asian Participants With BMS-986231
- Status
- COMPLETED
- Phase
- PHASE1
Study to Evaluate Effectiveness and Safety in Subjects With Moderate to Severe Psoriasis
- Status
- COMPLETED
- Phase
- PHASE2
Healthcare Cost and Resource Utilization Related to Metastatic Renal Cell Carcinoma Treatment With Intravenous and Oral Agents
- Status
- WITHDRAWN
- Phase
- N/A
A Study of Nivolumab Plus Brentuximab Vedotin in Patients Between 5 and 30 Years Old, With Hodgkin's Lymphoma (cHL), Relapsed or Refractory From First Line Treatment
- Status
- COMPLETED
- Phase
- PHASE2
The Drug Rediscovery Protocol (DRUP Trial)
- Status
- RECRUITING
- Phase
- PHASE2
A Phase II Trial of Ipilimumab and Nivolumab for the Treatment of Rare Cancers
- Status
- COMPLETED
- Phase
- PHASE2